These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15576291)

  • 1. Position of immunological techniques in screening in clinical toxicology.
    George S
    Clin Chem Lab Med; 2004; 42(11):1288-309. PubMed ID: 15576291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of point-of-care testing in the ED or ICU: a role for regional centralized toxicology laboratories.
    Wu AH
    Clin Pharmacol Ther; 2010 Sep; 88(3):295-8. PubMed ID: 20725077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control.
    Maurer HH
    Clin Chem Lab Med; 2004; 42(11):1310-24. PubMed ID: 15576292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair analysis in toxicology.
    Villain M; Cirimele V; Kintz P
    Clin Chem Lab Med; 2004; 42(11):1265-72. PubMed ID: 15576289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory and clinical evaluation of on-site urine drug testing.
    Beck O; Carlsson S; Tusic M; Olsson R; Franzen L; Hulten P
    Scand J Clin Lab Invest; 2014 Nov; 74(8):681-6. PubMed ID: 25046332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records.
    Hughey JJ; Colby JM
    Clin Chem; 2019 Dec; 65(12):1522-1531. PubMed ID: 31578215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced urine toxicology testing.
    Tenore PL
    J Addict Dis; 2010 Oct; 29(4):436-48. PubMed ID: 20924879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current technologies and considerations for drug bioanalysis in oral fluid.
    Gallardo E; Barroso M; Queiroz JA
    Bioanalysis; 2009 Jun; 1(3):637-67. PubMed ID: 21083159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in forensic toxicology.
    Peat MA
    Clin Lab Med; 1998 Jun; 18(2):263-78. PubMed ID: 9614587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoassay in healthcare testing applications.
    DePriest AZ; Black DL; Robert TA
    J Opioid Manag; 2015; 11(1):13-25. PubMed ID: 25750161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Use Disorders, Medication-Assisted Treatment, and the Role of the Laboratory.
    Bertholf RL; Reisfield GM
    Lab Med; 2017 Nov; 48(4):e57-e61. PubMed ID: 29096016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology consultation on urine compliance testing and drug abuse screening.
    Ward MB; Hackenmueller SA; Strathmann FG;
    Am J Clin Pathol; 2014 Nov; 142(5):586-93. PubMed ID: 25319972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction.
    Kunkel F; Fey E; Borg D; Stripp R; Getto C
    J Opioid Manag; 2015; 11(5):435-42. PubMed ID: 26535971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three commercial tests for buprenorphine screening in urine.
    Leino A; Loo BM
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.